1. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
2. New Maintenance Therapy Methods for Lung Cancer
3. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
4. New Chemotherapy Combination to be tested on Mesothelioma Patients
5. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
6. Finnish Study Could Lead to Better Lung Cancer Drug
7. New Lung Cancer Drug Starts Phase II Clinical Trial
8. Gene Screening Proves Effective in Screening for Mesothelioma Survival
9. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
10. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
11. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
12. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
13. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
14. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
15. Cancer Diagnosis From a Single Drop of Blood?
16. National mesothelioma virtual bank
17. Another Study Links Nanotubes To Mesothelioma
18. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
19. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
20. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
21. Research Shows Altered Immune Cells Target Mesothelin
22. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
23. Breakthrough Could Lead to New Cancer Therapies
24. Gene Fusions May Be Unique Identifier for Cancer
25. Study Examines Interactions Between Asbestos Fibers and Cells
26. Liver Tumors Treated with Chemotherapy Beads
27. Mesothelioma Researcher Receives Two Grants
28. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
29. Synthetic Material Attaches to Cells to Assist in Cancer Research
30. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
31. FDA Recommends Additional Clinical Trial for Onconase
32. ZenBio Awarded Phase II SBIR Grant for Cell Development
33. Researchers gain new insight into DNA replication
34. Study bolsters argument for treating cancer-related fatigue with exercise
35. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
36. Researchers report promising gene that causes cancer cells to self destruct
37. EPA awards $2.1 million asbestos research grant
38. Cancer research may exclude older patients
39. Vitamin supplements may not help prevent cancer
40. New treatments under development for asbestos-related cancer
41. Cancer treatment errors happen more than commonly known
42. Scientists develop nanotube technology to fight cancer cells
43. Study Shows Brief Inhibition of Cancer Cells is Effective
44. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
45. Vitamin trials for cancer prevention offer disappointing results
46. Supressing tumors in young patients may increase cancer risk in later years
47. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
48. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
49. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
50. Clinical trials struggling to attract participants
51. Study finds chemotherapy may be harmful For patients with advanced cancer
52. New cancer studies call anti-angiogenesis process into question
53. Scientists explore ways to use genes to fight cancer
54. Researchers find molecule that causes malignant cells to self-destruct
55. Research sheds light on lung cancer for non-smokers
56. Doctors look toward screening for lung cancer
57. Nanomaterial Screening helps determine which particles are toxic
58. Experts: Current pain treatment not sufficient for cancer patients
59. Massage could be beneficial for reducing cancer pain
60. New findings about chemotherapy at the molecular level
61. Transdermal patch developed for severe cancer pain
62. Too much Vitamin C may interfere with chemotherapy
63. New clues on causes of thoracic cancer
64. Telomerase gene sequence uncovered
65. Pleurodesis in the treatment and care of mesothelioma patients
66. Epigenetic drugs for cancer treatment
67. Study shows Alimta effective for maintenance therapy
68. Scientists announce advance in immunotherapy
69. Minimally invasive RFA treatment could be used for several cancer types
70. Novel strategy for cancer treatment uses patient's own blood
71. Attacking cancer stem cells a way to treat cancer
72. Predicting cancer-fighting abilities by computer
73. Anti-inflammatory drugs investigated for chemoprevention
74. Modified chemotherapy agent improves PET scan functioning
75. Government budget cuts deter progress in fight against cancer
76. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
77. Tumor Generator Could Enhance Cancer Drug Development
78. Belgian doctors hit personalized cancer treatment milestone
79. New biomarkers for cancer developed
80. New cancer medicines track records fail to live up to hype
81. New research initiative to map genetic mutations behind cancer
82. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
83. Personalized medicine holds promise
84. Arenegyr Receives Orphan Drug Designation for Mesothelioma
85. Onconase Phase IIIb Trial Posts Mixed Results
86. Study finds inaccuracies in some cancer treatment research.
87. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
88. New Study Tells Researchers How Cancer Spreads
89. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
90. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
91. Synthetic Molecules May Help Battle Cancer
92. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
93. Exercise Shown to Fend Off Fatigue Caused by Cancer
94. Nanoparticles Could Deliver Cancer Drugs
95. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
96. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
97. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
98. "Bacteria Therapy" Shows Promise in Initial Tests
99. New UCLA Machine May Kill Cancer Cells
100. Study raises doubts about some DNA-based drugs
101. Disease-Causing Bugs May Help Treat Cancer
102. New Cancer Vaccine Approved for Limited Use in Russia
103. New Therapy Targets Hepatitis C
104. Innovative New Cancer Treatment Idea Earns $1 Million Prize
105. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
106. Nanoparticles Help Advance Anticancer siRNA Therapy
107. Research at MIT Shows microRNA's Protective Role
108. Patients See Benefit From Self Reporting Symptoms Online
109. Cancer drugs from genetically modified chicken eggs
110. Researchers attempting to figure out how cancer grows
111. Antifolates - Chemotherapy drugs
112. Dopamine for cancer treatment
113. Concerns about anemia medications for cancer patients
114. Researchers Developing New Ways of Detecting Cancer
115. Recentin Study Ends
116. Phase II Study of Sutent ® Results Out
117. Terminally Ill Cancer Patients Given Hope in UK
118. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
119. PET Found to be effective in the Evaluation of Cancer Treatment
120. One-tird of cancer patients experience chronic fatigue after treatment
121. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
122. New DNA Discovery Changes the Way Doctors Look at Cancer.
123. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
124. Mouse Model For Mesothelioma Reproduces Human Disease
125. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
126. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
127. Remembering a researcher’s legacy on asbestos research
128. PET proves effective in evaluating cancer treatment
129. Trial on experimental antifolate PDX (Pralatrexate)
130. American College of Physicians releases guidelines for end-of-life care
131. Web-based system helps doctors track outpatients’ chemotherapy toxicity
132. NICE Gives Final Approval for Alimta
133. Par Pharmaceuticals licenses Onconase
134. Thalidomide and Alimta to be Combined in New Clinical Trial
135. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
136. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
137. Boysenberries might impede mesothelioma
138. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
139. New Mesothelioma Research Center to Open in Sydney
140. Virotherapy to Treat Mesothelioma
141. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
142. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
143. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
144. Researchers Identify Intracellular Pathway of Alfacell's Onconase
145. New Study
Heralds Shortened Timeline for Anticancer Drug Development
146. Talcum Powder Stunts Tumor Growth
147. Soluble mesothelin in effusions a strong indicator of mesothelioma
148. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
149. New Technology For Cancer Screening Listens For The Signs Of Cancer
150. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
151. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
152. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
153. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
154. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
155. Study shows Mesomark effective for monitoring Mesothelioma
156. FDA Grants Orphan Drug status to Onconase for Mesothelioma
157. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
158. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
159. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
160. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
161. Zolinza becomes first approved HDAC inhibitor
162. Alimta Researchers Recognized As Heroes Of Chemistry
163. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
164. FDA tells Eli Lilly that their Alimta brochure is misleading
165. News about onocology product candidate SS1P (renamed CAT-5001)
166. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
167. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
168. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
169. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
170. Scientist Reveals His Hopes for Better Tumour Treatment
171. Alfacell Drug Trial Ahead of Schedule
172. Alfacell Forms New Thoracic Cancer Advisory Board
173. Update on Onconase Clinical Program
174. Promising Research in Early Detection of Mesothelioma
175. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
176. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
177. Gene Drug Gives Mesothelioma Patient Second Chance
178. Novel therapies for pleural mesothelioma
179. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)
MesotheliomaWeb News Stories
Subscribe To
Posts
Comments